Fluoroquinolone-Containing Third-Line Regimen against Mycobacterium tuberculosis In Vivo
The objective of the present study was to compare the activities of a third-line regimen recommended by the World Health Organization (WHO) and two derivatives of that regimen with the activity of the standard combination of isoniazid, rifampin, and pyrazinamide as a positive control against Mycobac...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
2003
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC201131/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14506018/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.10.3117-3122.2003 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|